Review: Tissue engineering technology to enhance cell recruitment for regeneration therapy

Journal of Medical and Biological Engineering

Volumn 30, Issue 5, 2010, Pages 267-276

  Kohara, Hiroshi ^a   Tabata, Yasuhiko ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Chemoattractant; Recruitment; Regenerative medicine; Tissue engineering

Indexed keywords

CELL SOURCES; CELL SURVIVAL; CELL TRANSPLANTATION; CHEMOATTRACTANTS; HIGH POTENTIAL; HOST CELLS; IN-SITU; IN-VIVO; LOCAL ENVIRONMENTS; LOW RATES; PERIPHERAL BLOOD; RECRUITMENT; REGENERATIVE MEDICINE; SELF-HEALING; THERAPEUTIC EFFICACY; TISSUE REGENERATION;

BIOASSAY; BIOMATERIALS; CELLS; CYTOLOGY; EMPLOYMENT; TISSUE;

TISSUE ENGINEERING;

ALGINIC ACID; BIOMATERIAL; CHITIN; CHITOSAN; COLLAGEN; FIBRIN; GELATIN; HUMORAL ANTIBODY; HYALURONIC ACID; MACROGOL; POLYCAPROLACTONE; POLYGLYCOLIC ACID; POLYLACTIC ACID; SPHINGOSINE 1 PHOSPHATE;

CELL SURVIVAL; CELL TRANSPLANTATION; CIRCULATION; HEALING; HOST CELL; HUMAN; IN SITU HYBRIDIZATION; IN VIVO STUDY; REVIEW; STEM CELL; TISSUE ENGINEERING; TISSUE REGENERATION;

EID: 78149318020     PISSN: 16090985     EISSN: None     Source Type: Journal    
DOI: 10.5405/jmbe.30.5.01     Document Type: Review

References (152)

1. Y. Tabata, "Biomaterial technology for tissue engineering applications," J. R. Soc. Interface., 6 Suppl 3: S311-324, 2009.
2. R. Langer and J. P. Vacanti, "Tissue engineering," Science, 260: 920-926, 1993.
3. M. P. Lutolf, F. E. Weber, H. G. Schmoekel, J. C. Schense, T. Kohler, R. Muller and J. A. Hubbell, "Repair of bone defects using synthetic mimetics of collagenous extracellular matrices," Nat. Biotechnol., 21: 513-518, 2003.
4. S. MacNeil, "Progress and opportunities for tissue-engineered skin," Nature, 445: 874-880, 2007.
5. S. Levenberg, J. Rouwkema, M. Macdonald, E. S. Garfein, D. S. Kohane, D. C. Darland, R. Marini, C. A. van Blitterswijk, R. C. Mulligan, P. A. D'Amore and R. Langer, "Engineering vascularized skeletal muscle tissue," Nat. Biotechnol., 23: 879-884, 2005. (Pubitemid 43093132)
6. K. Ohashi, T. Yokoyama, M. Yamato, H. Kuge, H. Kanehiro, M. Tsutsumi, T. Amanuma, H. Iwata, J. Yang, T. Okano and Y. Nakajima, "Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets," Nat. Med., 13: 880-885, 2007.
7. L. E. Niklason, J. Gao, W. M. Abbott, K. K. Hirschi, S. Houser, R. Marini and R. Langer, "Functional arteries grown in vitro," Science, 284: 489-493, 1999.
8. S. Sundelacruz and D. L. Kaplan, "Stem cell- and scaffold-based tissue engineering approaches to osteochondral regenerative medicine," Semin. Cell Dev. Biol., 20: 646-655, 2009.
9. A. G. Mikos, S. W. Herring, P. Ochareon, J. Elisseeff, H. H. Lu, R. Kandel, F. J. Schoen, M. Toner, D. Mooney, A. Atala, M. E. Van Dyke, D. Kaplan and G. Vunjak-Novakovic, "Engineering complex tissues," Tissue Eng., 12: 3307-3339, 2006.
10. G. Zhang and L. J. Suggs, "Matrices and scaffolds for drug delivery in vascular tissue engineering," Adv. Drug. Deliv. Rev., 59: 360-373, 2007.
11. E. Engel, A. Michiardi, M. Navarro, D. Lacroix and J. A. Planell, "Nanotechnology in regenerative medicine: the materials side," Trends Biotechnol., 26: 39-47, 2008.
12. M. P. Lutolf, P. M. Gilbert and H. M. Blau, "Designing materials to direct stem-cell fate," Nature, 462: 433-441, 2009.
13. D. E. Discher, D. J. Mooney and P. W. Zandstra, "Growth factors, matrices, and forces combine and control stem cells," Science, 324: 1673-1677, 2009.
14. N. Zippel, M. Schulze and E. Tobiasch, "Biomaterials and mesenchymal stem cells for regenerative medicine," Recent Pat. Biotechnol., 4: 1-22, 2010.
15. W. L. Grayson, T. P. Martens, G. M. Eng, M. Radisic and G. Vunjak-Novakovic, "Biomimetic approach to tissue engineering," Semin. Cell Dev. Biol., 20: 665-673, 2009.
16. Y. Gu, Y. Tabata, Y. Kawakami, A. N. Balamurugan, H. Hori, N. Nagata, A. Satake, W. Cui, M. Qi, Y. Misawa, M. Toma, M. Miyamoto, M. Nozawa, and K. Inoue, "Development of a new method to induce angiogenesis at subcutaneous site of streptozotocin-induced diabetic rats for islet transplantation," Cell Transplant., 10: 453-457, 2001.
17. A. N. Balamurugan, Y.Gu, Y. Tabata, M. Miyamoto, W. Cui, H. Hori, A. Satake, N. Nagata, W. Wang, and K. Inoue, "Bioartificial pancreas transplantation at prevascularized intermuscular space: effect of angiogenesis induction on islet survival," Pancreas, 26: 279-285, 2003.
18. M. Kuwana, Y. Okazaki, H. Kodama, K. Izumi, H. Yasuoka, Y. Ogawa, Y. Kawakami and Y. Ikeda, "Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation," J. Leukoc. Biol., 74: 833-845, 2003.
19. N. Seta and M. Kuwana, "Human circulating monocytes as multipotential progenitors," Keio J. Med., 56: 41-47, 2007.
20. J. W. Goodman and G. S. Hodgson, "Evidence for stem cells in the peripheral blood of mice," Blood, 19: 702-714, 1962.
21. D. D. Ross, A. Pollak, S. A. Akman and N. R. Bachur, "Diurnal variation of circulating human myeloid progenitor cells," Exp. Hematol., 8: 954-960, 1980.
22. D. S. Verma, R. Fisher, G. Spitzer, A. R. Zander, K. B. McCredie and K. A. Dicke, "Diurnal changes in circulating myeloid progenitor cells in man," Am. J. Hematol., 9: 185-192, 1980. (Pubitemid 11199275)
23. B. A. Schwarz and A. Bhandoola, "Circulating hematopoietic progenitors with T lineage potential," Nat. Immunol., 5: 953-960, 2004.
24. A. Krueger and H. von Boehmer, "Identification of a T lineage-committed progenitor in adult blood," Immunity, 26: 105-116, 2007.
25. S. A. Kuznetsov, M. H. Mankani, S. Gronthos, K. Satomura, P. Bianco and P. G. Robey, "Circulating skeletal stem cells," J. Cell Biol., 153: 1133-1140, 2001.
26. G. Z. Eghbali-Fatourechi, J. Lamsam, D. Fraser, D. Nagel, B. L. Riggs and S. Khosla, "Circulating osteoblast-lineage cells in humans," N. Engl. J. Med., 352: 1959-1966, 2005.
27. T. Asahara, T. Murohara, A. Sullivan, M. Silver, R. van der Zee, T. Li, B. Witzenbichler, G. Schatteman and J. M. Isner, "Isolation of putative progenitor endothelial cells for angiogenesis," Science, 275: 964-967, 1997.
28. Q. Shi, S. Rafii, M. H. Wu, E. S. Wijelath, C. Yu, A. Ishida, Y. Fujita, S. Kothari, R. Mohle, L. R. Sauvage, M. A. Moore, R. F. Storb and W. P. Hammond, "Evidence for circulating bone marrow-derived endothelial cells," Blood, 92: 362-367, 1998.
29. T. Asahara, H. Masuda, T. Takahashi, C. Kalka, C. Pastore, M. Silver, M. Kearne, M. Magner and J. M. Isner, "Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization," Circ. Res., 85: 221-228, 1999.
30. M. Fernandez, V. Simon, G. Herrera, C. Cao, H. Del Favero and J. J. Minguell, "Detection of stromal cells in peripheral blood progenitor cell collections from breast cancer patients," Bone Marrow Transplant., 20: 265-271, 1997.
31. N. J. Zvaifler, L. Marinova-Mutafchieva, G. Adams, C. J. Edwards, J. Moss, J. A. Burger and R. N. Maini, "Mesenchymal precursor cells in the blood of normal individuals," Arthritis Res., 2: 477-488, 2000.
32. E. Mansilla, G. H. Marin, H. Drago, F. Sturla, E. Salas, C. Gardiner, S. Bossi, R. Lamonega, A. Guzman, A. Nunez, M. A. Gil, G. Piccinelli, R. Ibar and C. Soratti, "Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence for their use in regenerative medicine," Transplant. Proc., 38: 967-969, 2006.
33. Y. Wang, H. E. Johnsen, S. Mortensen, L. Bindslev, R. S. Ripa, M. Haack-Sorensen, E. Jorgensen, W. Fang and J. Kastrup, "Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention," Heart, 92: 768-774, 2006.
34. J. M. Fox, G. Chamberlain, B. A. Ashton and J. Middleton, "Recent advances into the understanding of mesenchymal stem cell trafficking," Br. J. Haematol., 137: 491-502, 2007.
35. D. S. Krause, "Plasticity of marrow-derived stem cells," Gene Ther., 9: 754-758, 2002.
36. S. Otsuru, K. Tamai, T. Yamazaki, H. Yoshikawa and Y. Kaneda, "Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice," Biochem. Biophys. Res. Commun., 354: 453-458, 2007.
37. S. Otsuru, K. Tamai, T. Yamazaki, H. Yoshikawa and Y. Kaneda, "Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway," Stem Cells, 26: 223-234, 2008.
38. O. M. Tepper, J. M. Capla, R. D. Galiano, D. J. Ceradini, M. J. Callaghan, M. E. Kleinman and G. C. Gurtner, "Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells," Blood, 105: 1068-1077, 2005.
39. M. Gill, S. Dias, K. Hattori, M. L. Rivera, D. Hicklin, L. Witte, L. Girardi, R. Yurt, H. Himel and S. Rafii, "Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells," Circ. Res., 88: 167-174, 2001.
40. J. G. Cyster, "Chemokines and cell migration in secondary lymphoid organs," Science, 286: 2098-2102, 1999.
41. K. Tashiro, H. Tada, R. Heilker, M. Shirozu, T. Nakano and T. Honjo, "Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins," Science, 261: 600-603, 1993.
42. T. Nagasawa, H. Kikutani and T. Kishimoto, "Molecular cloning and structure of a pre-B-cell growth-stimulating factor," Proc. Natl. Acad. Sci. U S A., 91: 2305-2309, 1994. (Pubitemid 24092092)
43. T. Nagasawa, S. Hirota, K. Tachibana, N. Takakura, S. Nishikawa, Y. Kitamura, N. Yoshida, H. Kikutani and T. Kishimoto, "Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1," Nature, 382: 635-638, 1996.
44. T. Nagasawa, "Microenvironmental niches in the bone marrow required for B-cell development," Nat. Rev. Immunol., 6: 107-116, 2006.
45. Y. R. Zou, A. H. Kottmann, M. Kuroda, I. Taniuchi and D. R. Littman, "Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development," Nature, 393: 595-599, 1998.
46. K. Tachibana, S. Hirota, H. Iizasa, H. Yoshida, K. Kawabata, Y. Kataoka, Y. Kitamura, K. Matsushima, N. Yoshida, S. Nishikawa, T. Kishimoto and T. Nagasawa, "The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract," Nature, 393: 591-594, 1998.
47. R. B. Maksym, M. Tarnowski, K. Grymula, J. Tarnowska, M. Wysoczynski, R. Liu, B. Czerny, J. Ratajczak, M. Kucia and M. Z. Ratajczak, "The role of stromal-derived factor-1-CXCR7 axis in development and cancer," Eur. J. Pharmacol., 625: 31-40, 2009.
48. T. Ara, K. Tokoyoda, T. Sugiyama, T. Egawa, K. Kawabata and T. Nagasawa, "Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny," Immunity, 19: 257-267, 2003.
49. I. Kryczek, S. Wei, E. Keller, R. Liu and W. Zou, "Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis," Am. J. Physiol. Cell Physiol., 292: C987-995, 2007.
50. T. Nagase, N. Seki, K. Ishikawa, M. Ohira, Y. Kawarabayasi, O. Ohara, A. Tanaka, H. Kotani, N. Miyajima and N. Nomura, "Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain," DNA Res., 3: 321-329, 341-354, 1996.
51. Y. Fukui, O. Hashimoto, T. Sanui, T. Oono, H. Koga, M. Abe, A. Inayoshi, M. Noda, M. Oike, T. Shirai and T. Sasazuki, "Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration," Nature, 412: 826-831, 2001.
52. T. Sugiyama, H. Kohara, M. Noda and T. Nagasawa, "Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches," Immunity, 25: 977-988, 2006.
53. T. Egawa, K. Kawabata, H. Kawamoto, K. Amada, R. Okamoto, N. Fujii, T. Kishimoto, Y. Katsura and T. Nagasawa, "The earliest stages of B cell development require a chemokine stromal cell-derived factor/pre-B cell growth-stimulating factor," Immunity, 15: 323-334, 2001.
54. H. Kohara, Y. Omatsu, T. Sugiyama, M. Noda, N. Fujii and T. Nagasawa, "Development of plasmacytoid dendritic cells in bone marrow stromal cell niches requires CXCL12-CXCR4 chemokine signaling," Blood, 110: 4153-4160, 2007.
55. T. Ara, K. Tokoyoda, R. Okamoto, P. A. Koni and T. Nagasawa, "The role of CXCL12 in the organ-specific process of artery formation," Blood, 105: 3155-3161, 2005.
56. H. Shim, S. Oishi and N. Fujii, "Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors," Semin. Cancer Biol., 19: 123-134, 2009.
57. E. De Clercq, "Inhibition of HIV infection by bicyclams, highly potent and specific CXCR4 antagonists," Mol. Pharmacol., 57: 833-839, 2000.
58. D. Wong and W. Korz, "Translating an antagonist of chemokine receptor CXCR4: from bench to bedside," Clin. Cancer Res., 14: 7975-7980, 2008.
59. M. R. Urist, "Bone: formation by autoinduction," Science, 150: 893-899, 1965.
60. Y. Kimura, N. Miyazaki, N. Hayashi, S. Otsuru, K. Tamai, Y. Kaneda and Y. Tabata, "Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue," Tissue Eng. Part A., 2009.
61. T. Kitaori, H. Ito, E. M. Schwarz, R. Tsutsumi, H. Yoshitomi, S. Oishi, M. Nakano, N. Fujii, T. Nagasawa and T. Nakamura, "Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model," Arthritis Rheum., 60: 813-823, 2009.
62. M. Lind, E. F. Eriksen and C. Bunger, "Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells," Bone, 18: 53-57, 1996.
63. H. Peng, V. Wright, A. Usas, B. Gearhart, H. C. Shen, J. Cummins and J. Huard, "Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4," J. Clin. Invest., 110: 751-759, 2002.
64. S. Imai, M. Kaksonen, E. Raulo, T. Kinnunen, C. Fages, X. Meng, M. Lakso and H. Rauvala, "Osteoblast recruitment and bone formation enhanced by cell matrix-associated heparin-binding growth-associated molecule (HB-GAM)," J. Cell Biol., 143: 1113-1128, 1998.
65. B. A. Bladergroen, B. Siebum, K. G. Siebers-Vermeulen, T. H. Van Kuppevelt, A. A. Poot, J. Feijen, C. G. Figdor and R. Torensma, "In vivo recruitment of hematopoietic cells using stromal cell-derived factor 1 alpha-loaded heparinized three-dimensional collagen scaffolds," Tissue Eng. Part A., 15: 1591-1599, 2009.
66. P. T. Thevenot, A. M. Nair, J. Shen, P. Lotfi, C. Y. Ko and L. Tang, "The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response," Biomaterials, 31: 3997-4008, 2010.
67. S. Spiegel and S. Milstien, "Sphingosine-1-phosphate: an enigmatic signalling lipid," Nat. Rev. Mol. Cell Biol., 4: 397-407, 2003.
68. S. R. Schwab, J. P. Pereira, M. Matloubian, Y. Xu, Y. Huang and J. G. Cyster, "Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients," Science, 309: 1735-1739, 2005.
69. H. Rosen and E. J. Goetzl, "Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network," Nat. Rev. Immunol., 5: 560-570, 2005.
70. R. Pappu, S. R. Schwab, I. Cornelissen, J. P. Pereira, J. B. Regard, Y. Xu, E. Camerer, Y. W. Zheng, Y. Huang, J. G. Cyster and S. R. Coughlin, "Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate," Science, 316: 295-298, 2007.
71. A. Olivera, T. Kohama, Z. Tu, S. Milstien and S. Spiegel, "Purification and characterization of rat kidney sphingosine kinase," J. Biol. Chem., 273: 12576-12583, 1998.
72. T. Kohama, A. Olivera, L. Edsall, M. M. Nagiec, R. Dickson and S. Spiegel, "Molecular cloning and functional characterization of murine sphingosine kinase," J. Biol. Chem., 273: 23722-23728, 1998.
73. H. Liu, M. Sugiura, V. E. Nava, L. C. Edsall, K. Kono, S. Poulton, S. Milstien, T. Kohama and S. Spiegel, "Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform," J. Biol. Chem., 275: 19513-19520, 2000.
74. M. L. Allende, T. Sasaki, H. Kawai, A. Olivera, Y. Mi, G. van Echten-Deckert, R. Hajdu, M. Rosenbach, C. A. Keohane, S. Mandala, S. Spiegel and R. L. Proia, "Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720," J. Biol. Chem., 279: 52487-52492, 2004.
75. M. Matloubian, C. G. Lo, G. Cinamon, M. J. Lesneski, Y. Xu, V. Brinkmann, M. L. Allende, R. L. Proia and J. G. Cyster, "Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1," Nature, 427: 355-360, 2004.
76. S. Mandala, R. Hajdu, J. Bergstrom, E. Quackenbush, J. Xie, J. Milligan, R. Thornton, G. J. Shei, D. Card, C. Keohane, M. Rosenbach, J. Hale, C. L. Lynch, K. Rupprecht, W. Parsons and H. Rosen, "Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists," Science, 296: 346-349, 2002.
77. V. Brinkmann, M. D. Davis, C. E. Heise, R. Albert, S. Cottens, R. Hof, C. Bruns, E. Prieschl, T. Baumruker, P. Hiestand, C. A. Foster, M. Zollinger and K. R. Lynch, "The immune modulator FTY720 targets sphingosine 1-phosphate receptors," J. Biol. Chem., 277: 21453-21457, 2002.
78. K. Chiba, Y. Yanagawa, Y. Masubuchi, H. Kataoka, T. Kawaguchi, M. Ohtsuki and Y. Hoshino, "FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing," J. Immunol., 160: 5037-5044, 1998.
79. H. Yagi, R. Kamba, K. Chiba, H. Soga, K. Yaguchi, M. Nakamura and T. Itoh, "Immunosuppressant FTY720 inhibits thymocyte emigration," Eur. J. Immunol., 30: 1435-1444, 2000.
80. E. J. Sinkeldam, A. P. de Groot, H. van den Berg and C. I. Chappel, "The effect of pyridoxine on the number of lymphocytes in the blood of rats fed caramel colour (III)," Food Chem. Toxicol., 26: 195-203, 1988.
81. R. Gugasyan, A. Coward, L. O'Connor, K. Shortman and R. Scollay, "Emigration of mature T cells from the thymus is inhibited by the imidazole-based compound 2-acetyl-4-tetrahydroxybutylimidazole," Immunology, 93: 398-404, 1998.
82. E. Kupperman, S. An, N. Osborne, S. Waldron and D. Y. Stainier, "A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development," Nature, 406: 192-195, 2000.
83. Y. Liu, R. Wada, T. Yamashita, Y. Mi, C. X. Deng, J. P. Hobson, H. M. Rosenfeldt, V. E. Nava, S. S. Chae, M. J. Lee, C. H. Liu, T. Hla, S. Spiegel and R. L. Proia, "Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation," J. Clin. Invest., 106: 951-961, 2000.
84. K. Mizugishi, T. Yamashita, A. Olivera, G. F. Miller, S. Spiegel and R. L. Proia, "Essential role for sphingosine kinases in neural and vascular development," Mol. Cell Biol., 25: 11113-11121, 2005.
85. F. Paris, G. I. Perez, Z. Fuks, A. Haimovitz-Friedman, H. Nguyen, M. Bose, A. Ilagan, P. A. Hunt, W. F. Morgan, J. L. Tilly and R. Kolesnick, "Sphingosine 1-phosphate preserves fertility in irradiated female mice without propagating genomic damage in offspring," Nat. Med., 8: 901-902, 2002.
86. X. Qi, Y. Okamoto, T. Murakawa, F. Wang, O. Oyama, R. Ohkawa, K. Yoshioka, W. Du, N. Sugimoto, Y. Yatomi, N. Takuwa and Y. Takuwa, "Sustained delivery of sphingosine-1-phosphate using poly(lactic-co- glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice," Eur. J. Pharmacol., 2010.
87. J. J. Moon, J. E. Saik, R. A. Poche, J. E. Leslie-Barbick, S. H. Lee, A. A. Smith, M. E. Dickinson and J. L. West, "Biomimetic hydrogels with pro-angiogenic properties," Biomaterials, 31: 3840-3847, 2010.
88. M. Ono, H. Torisu, J. Fukushi, A. Nishie and M. Kuwano, "Biological implications of macrophage infiltration in human tumor angiogenesis," Cancer Chemother. Pharmacol., 43 Suppl: S69-71, 1999.
89. A. E. Dirkx, M. G. Oude Egbrink, J. Wagstaff and A. W. Griffioen, "Monocyte/macrophage infiltration in tumors: modulators of angiogenesis," J. Leukoc. Biol., 80: 1183-1196, 2006.
90. S. Tazzyman, C. E. Lewis and C. Murdoch, "Neutrophils: key mediators of tumour angiogenesis," Int. J. Exp. Pathol., 90: 222-231, 2009.
91. A. W. Burgess, J. Camakaris and D. Metcalf, "Purification and properties of colony-stimulating factor from mouse lung-conditioned medium," J. Biol. Chem., 252: 1998-2003, 1977.
92. T. R. Hercus, D. Thomas, M. A. Guthridge, P. G. Ekert, J. King-Scott, M. W. Parker and A. F. Lopez, "The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease," Blood, 114: 1289-1298, 2009.
93. J. M. Wang, Z. G. Chen, F. Colotta and A. Mantovani, "Role of GM-CSF in phagocyte recruitment and regulation of c-fos protooncogene expression," Behring. Inst. Mitt., 270-273, 1988.
94. M. C. Dieu, B. Vanbervliet, A. Vicari, J. M. Bridon, E. Oldham, S. Ait-Yahia, F. Briere, A. Zlotnik, S. Lebecque and C. Caux, "Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites," J. Exp. Med., 188: 373-386, 1998.
95. M. J. Muessel, K. S. Scott, P. Friedl, P. Bradding and A. J. Wardlaw, "CCL11 and GM-CSF differentially use the Rho GTPase pathway to regulate motility of human eosinophils in a three-dimensional microenvironment," J. Immunol., 180: 8354-8360, 2008.
96. D. J. Irvine, A. N. Stachowiak and Y. Hori, "Lymphoid tissue engineering: invoking lymphoid tissue neogenesis in immunotherapy and models of immunity," Semin. Immunol., 20: 137-146, 2008.
97. Y. Hori, A. M. Winans, C. C. Huang, E. M. Horrigan and D. J. Irvine, "Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy," Biomaterials, 29: 3671-3682, 2008.
98. Y. Hori, P. J. Stern, R. O. Hynes and D. J. Irvine, "Engulfing tumors with synthetic extracellular matrices for cancer immunotherapy," Biomaterials, 30: 6757-6767, 2009.
99. O. A. Ali, N. Huebsch, L. Cao, G. Dranoff and D. J. Mooney, "Infection-mimicking materials to program dendritic cells in situ," Nat. Mater., 8: 151-158, 2009.
100. R. Levi-Montalcini, S. D. Skaper, R. Dal Toso, L. Petrelli and A. Leon, "Nerve growth factor: from neurotrophin to neurokine," Trends Neurosci., 19: 514-520, 1996.
101. C. Crowley, S. D. Spencer, M. C. Nishimura, K. S. Chen, S. Pitts-Meek, M. P. Armanini, L. H. Ling, S. B. McMahon, D. L. Shelton, A. D. Levinson and et al., "Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons," Cell, 76: 1001-1011, 1994.
102. A. M. Colangelo, N. Finotti, M. Ceriani, L. Alberghina, E. Martegani, L. Aloe, L. Lenzi and R. Levi-Montalcini, "Recombinant human nerve growth factor with a marked activity in vitro and in vivo," Proc. Natl. Acad. Sci. U S A., 102: 18658-18663, 2005.
103. W. Zeng, W. Yuan, L. Li, J. Mi, S. Xu, C. Wen, Z. Zhou, J. Xiong, J. Sun, D. Ying, M. Yang, X. Li and C. Zhu, "The promotion of endothelial progenitor cells recruitment by nerve growth factors in tissue-engineered blood vessels," Biomaterials, 31: 1636-1645, 2010.
104. C. Mikelis and E. Papadimitriou, "Heparin-binding protein pleiotrophin: an important player in the angiogenic process," Connect. Tissue. Res., 49: 149-152, 2008.
105. C. C. Rider, "Heparin/heparan sulphate binding in the TGF-beta cytokine superfamily," Biochem. Soc. Trans., 34: 458-460, 2006.
106. S. M. Cool and V. Nurcombe, "Heparan sulfate regulation of progenitor cell fate," J. Cell Biochem., 99: 1040-1051, 2006.
107. K. D. Rodgers, J. D. San Antonio and O. Jacenko, "Heparan sulfate proteoglycans: a GAGgle of skeletal-hematopoietic regulators," Dev. Dyn., 237: 2622-2642, 2008.
108. S. Kishimoto, F. Oonuma, S. Nakamura, H. Hattori, Y. Mori, Y. Tanaka, Y. Harada, M. Tagawa and M. Ishihara, "Immobilization, stabilization, and activation of human stem cell factor (SCF) on fragmin/protamine microparticle (F/P MP)-coated plates," J. Biomed. Mater. Res. B Appl. Biomater., 92: 32-39, 2010.
109. Y. Ito, G. Chen and Y. Imanishi, "Artificial juxtacrine stimulation for tissue engineering," J. Biomater. Sci. Polym. Ed., 9: 879-890, 1998.
110. R. Vasita and D. S. Katti, "Growth factor-delivery systems for tissue engineering: a materials perspective," Expert. Rev. Med. Devices., 3: 29-47, 2006.
111. J. K. Tessmar and A. M. Gopferich, "Matrices and scaffolds for protein delivery in tissue engineering," Adv. Drug. Deliv. Rev., 59: 274-291, 2007.
112. K. Alberti, R. E. Davey, K. Onishi, S. George, K. Salchert, F. P. Seib, M. Bornhauser, T. Pompe, A. Nagy, C. Werner and P. W. Zandstra, "Functional immobilization of signaling proteins enables control of stem cell fate," Nat. Methods., 5: 645-650, 2008.
113. G. Chen, Y. Ito and Y. Imanishi, "Photo-immobilization of epidermal growth factor enhances its mitogenic effect by artificial juxtacrine signaling," Biochim. Biophys. Acta., 1358: 200-208, 1997.
114. Y. Ito, G. Chen and Y. Imanishi, "Micropatterned immobilization of epidermal growth factor to regulate cell function," Bioconjug. Chem., 9: 277-282, 1998.
115. G. Chen and Y. Ito, "Gradient micropattern immobilization of EGF to investigate the effect of artificial juxtacrine stimulation," Biomaterials, 22: 2453-2457, 2001.
116. T. J. Stefonek-Puccinelli and K. S. Masters, "Co-immobilization of gradient-patterned growth factors for directed cell migration," Ann. Biomed. Eng., 36: 2121-2133, 2008.
117. B. Varnum-Finney, L. Wu, M. Yu, C. Brashem-Stein, S. Staats, D. Flowers, J. D. Griffin and I. D. Bernstein, "Immobilization of Notch ligand, Delta-1, is required for induction of notch signaling," J. Cell Sci., 113 Pt 23: 4313-4318, 2000.
118. B. L. Beckstead, D. M. Santosa and C. M. Giachelli, "Mimicking cell-cell interactions at the biomaterial-cell interface for control of stem cell differentiation," J. Biomed. Mater. Res. A., 79: 94-103, 2006.
119. R. M. Goncalves, M. C. Martins, G. Almeida-Porada and M. A. Barbosa, "Induction of notch signaling by immobilization of jagged-1 on self-assembled monolayers," Biomaterials, 30: 6879-6887, 2009.
120. J. S. Kim, V. S. McKinnis and S. R. White, "Migration of guinea pig airway epithelial cells in response to bombesin analogues," Am. J. Respir. Cell Mol. Biol., 16: 259-266, 1997.
121. K. A. Yule and S. R. White, "Migration of 3T3 and lung fibroblasts in response to calcitonin gene-related peptide and bombesin," Exp. Lung. Res., 25: 261-273, 1999.
122. T. Talme, Z. Liu and K. G. Sundqvist, "The neuropeptide calcitonin gene-related peptide (CGRP) stimulates T cell migration into collagen matrices," J. Neuroimmunol., 196: 60-66, 2008.
123. S. Dunzendorfer, C. Meierhofer and C. J. Wiedermann, "Signaling in neuropeptide-induced migration of human eosinophils," J. Leukoc. Biol., 64: 828-834, 1998.
124. T. H. Achmad and G. S. Rao, "Chemotaxis of human blood monocytes toward endothelin-1 and the influence of calcium channel blockers," Biochem. Biophys. Res. Commun., 189: 994-1000, 1992.
125. J. G. Elferink and B. M. de Koster, "Endothelin-induced activation of neutrophil migration," Biochem. Pharmacol., 48: 865-871, 1994.
126. T. Horikawa, D. A. Norris, J. J. Yohn, T. Zekman, J. B. Travers and J. G. Morelli, "Melanocyte mitogens induce both melanocyte chemokinesis and chemotaxis," J. Invest. Dermatol., 104: 256-259, 1995.
127. L. Morbidelli, C. Orlando, C. A. Maggi, F. Ledda and M. Ziche, "Proliferation and migration of endothelial cells is promoted by endothelins via activation of ETB receptors," Am. J. Physiol., 269: H686-695, 1995.
128. H. H. Wang, H. L. Hsieh, C. Y. Wu and C. M. Yang, "Endothelin-1 enhances cell migration via matrix metalloproteinase-9 up-regulation in brain astrocytes," J. Neurochem., 2010.
129. P. Brun, C. Mastrotto, E. Beggiao, A. Stefani, L. Barzon, G. C. Sturniolo, G. Palu and I. Castagliuolo, "Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation," Am. J. Physiol. Gastrointest. Liver Physiol., 288: G621-629, 2005.
130. D. Yang, O. Chertov, S. N. Bykovskaia, Q. Chen, M. J. Buffo, J. Shogan, M. Anderson, J. M. Schroder, J. M. Wang, O. M. Howard and J. J. Oppenheim, "Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6," Science, 286: 525-528, 1999.
131. W. Heagy, M. Laurance, E. Cohen and R. Finberg, "Neurohormones regulate T cell function," J. Exp. Med., 171: 1625-1633, 1990.
132. D. Yang, O. Chertov and J. J. Oppenheim, "Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37)," J. Leukoc. Biol., 69: 691-697, 2001.
133. D. E. van Epps and L. Saland, "Beta-endorphin and met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis," J. Immunol., 132: 3046-3053, 1984.
134. M. Moriyama, S. Fukuyama, H. Inoue, T. Matsumoto, T. Sato, K. Tanaka, I. Kinjyo, T. Kano, A. Yoshimura and M. Kojima, "The neuropeptide neuromedin U activates eosinophils and is involved in allergen-induced eosinophilia," Am. J. Physiol. Lung Cell Mol. Physiol., 290: L971-977, 2006.
135. M. De la Fuente, I. Bernaez, M. Del Rio and A. Hernanz, "Stimulation of murine peritoneal macrophage functions by neuropeptide Y and peptide YY: involvement of protein kinase C," Immunology, 80: 259-265, 1993.
136. G. Ghersi, W. Chen, E. W. Lee and Z. Zukowska, "Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding," Peptides, 22: 453-458, 2001.
137. M. Decressac, L. Prestoz, J. Veran, A. Cantereau, M. Jaber and A. Gaillard, "Neuropeptide Y stimulates proliferation, migration and differentiation of neural precursors from the subventricular zone in adult mice," Neurobiol. Dis., 34: 441-449, 2009.
138. M. Lee, M. Hadi, G. Hallden and G. W. Aponte, "Peptide YY and neuropeptide Y induce villin expression, reduce adhesion, and enhance migration in small intestinal cells through the regulation of CD63, matrix metalloproteinase-3, and Cdc42 activity," J. Biol. Chem., 280: 125-136, 2005.
139. C. Feistritzer, B. A. Mosheimer, D. Colleselli, C. J. Wiedermann and C. M. Kahler, "Effects of the neuropeptide secretoneurin on natural killer cell migration and cytokine release," Regul. Pept., 126: 195-201, 2005.
140. C. M. Kahler, P. Schratzberger, G. Kaufmann, B. Hochleitner, O. Bechter, C. Gotsch, E. Woll, P. Marschang, M. Herold and C. J. Wiedermann, "Transendothelial migration of leukocytes and signalling mechanisms in response to the neuropeptide secretoneurin," Regul. Pept., 105: 35-46, 2002.
141. H. Oulyadi, D. Davoust and H. Vaudry, "A determination of the solution conformation of secretoneurin, a neuropeptide originating from the processing of secretogranin II, by 1H-NMR and restrained molecular dynamics," Eur. J. Biochem., 246: 665-673, 1997.
142. C. M. Kahler, G. Kaufmann, R. Hogue-Angeletti, R. Fischer-Colbrie, S. Dunzendorfer, N. Reinisch and C. J. Wiedermann, "A soluble gradient of the neuropeptide secretoneurin promotes the transendothelial migration of monocytes in vitro," Eur. J. Pharmacol., 365: 65-75, 1999.
143. N. Reinisch, R. Kirchmair, C. M. Kahler, R. Hogue-Angeletti, R. Fischer-Colbrie, H. Winkler and C. J. Wiedermann, "Attraction of human monocytes by the neuropeptide secretoneurin," FEBS Lett., 334: 41-44, 1993.
144. S. Dunzendorfer, P. Schratzberger, N. Reinisch, C. M. Kahler and C. J. Wiedermann, "Secretoneurin, a novel neuropeptide, is a potent chemoattractant for human eosinophils," Blood, 91: 1527-1532, 1998.
145. C. M. Kahler, P. Schratzberger and C. J. Wiedermann, "Response of vascular smooth muscle cells to the neuropeptide secretoneurin: a functional role for migration and proliferation in vitro," Arterioscler. Thromb. Vasc. Biol., 17: 2029-2035, 1997.
146. C. M. Kahler, R. Bellmann, N. Reinisch, P. Schratzberger, B. Gruber and C. J. Wiedermann, "Stimulation of human skin fibroblast migration by the neuropeptide secretoneurin," Eur. J. Pharmacol., 304: 135-139, 1996.
147. W. A. Marasco, H. J. Showell and E. L. Becker, "Substance P binds to the formylpeptide chemotaxis receptor on the rabbit neutrophil," Biochem. Biophys. Res. Commun., 99: 1065-1072, 1981.
148. M. R. Ruff, S. M. Wahl and C. B. Pert, "Substance P receptor-mediated chemotaxis of human monocytes," Peptides, 6 Suppl 2: 107-111, 1985.
149. T. Numao and D. K. Agrawal, "Neuropeptides modulate human eosinophil chemotaxis," J. Immunol., 149: 3309-3315, 1992.
150. C. Feistritzer, J. Clausen, D. H. Sturn, A. Djanani, E. Gunsilius, C. J. Wiedermann and C. M. Kahler, "Natural killer cell functions mediated by the neuropeptide substance P," Regul. Pept., 116: 119-126, 2003.
151. M. Ziche, L. Morbidelli, P. Geppetti, C. A. Maggi and P. Dolara, "Substance P induces migration of capillary endothelial cells: a novel NK-1 selective receptor mediated activity," Life Sci., 48: PL7-11, 1991.
152. C. M. Kahler, B. A. Sitte, N. Reinisch and C. J. Wiedermann, "Stimulation of the chemotactic migration of human fibroblasts by substance P," Eur. J. Pharmacol., 249: 281-286, 1993..